Clinical trial
A Phase 2, Open-label Extension Study to Evaluate Long-term Safety of MEDI-546 in Adults With Systemic Lupus Erythematosus
NCT01753193 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Open-label Extension Study to Evaluate Long-term Safety of MEDI-546 in Adults With Systemic Lupus Erythematosus
- Lead sponsor
- MedImmune LLC
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 28, 2013
- Completion date
- July 18, 2018
- Enrollment
- 218 (actual)
- Sites
- 57
Conditions
As the registry lists them; a condition with its own page is linked.